82 results
Page 2 of 5
8-K
bwrt112p41mwpf
6 Dec 22
Equillium and Ono Pharmaceutical Announce Exclusive Option and Asset Purchase Agreement for the Development and Commercialization of Itolizumab
7:00am
425
ry7c1dlwtxo13j
14 Nov 22
Business combination disclosure
4:20pm
8-K
EX-99.1
6si4v73qzizz7pabsp7r
14 Nov 22
Equillium Reports Third Quarter 2022 Financial Results and Provides Corporate and Clinical Updates
4:10pm
424B3
nh2hbsk
10 Nov 22
Prospectus supplement
4:13pm
S-4/A
9lt0 1plu
9 Nov 22
Registration of securities issued in business combination transactions (amended)
4:31pm
S-4
y0tfpx2g2ep1mp9j
26 Oct 22
Registration of securities issued in business combination transactions
9:59pm
425
tsqhpi7t
27 Sep 22
Business combination disclosure
9:30am
8-K
EX-99.1
7jxkhds6
27 Sep 22
Other Events
9:28am
8-K
srfw d4f72
27 Sep 22
Other Events
9:28am
425
jzs r1zf13dmy
26 Sep 22
Business combination disclosure
5:29pm
8-K
ygblf1xqjz0ug78i6
26 Sep 22
Report of Independent Registered Public Accounting Firm
5:27pm
425
3qu6tjg 7gxrm
6 Sep 22
Business combination disclosure
4:33pm
8-K
EX-2.1
cxiry3wnxweybl
6 Sep 22
Equillium to Acquire Metacrine in All-Stock Transaction
4:29pm
8-K
EX-99.1
b8z jh1v2zfne38l
6 Sep 22
Equillium to Acquire Metacrine in All-Stock Transaction
4:29pm
8-K
bxum2ph3
6 Sep 22
Equillium to Acquire Metacrine in All-Stock Transaction
4:29pm
8-K
EX-99.2
zns8qr jy40y1jzx
6 Sep 22
Equillium to Acquire Metacrine in All-Stock Transaction
4:29pm
DEFA14A
hr009
13 Apr 22
Additional proxy soliciting materials
4:09pm